The World Clinical Biomarkers & CDx Summit returns for the 11th year!
The World Clinical Biomarkers & CDx Summit returns for the 11th year! Once again uniting the Biomarker and Diagnostic community from across Biopharma, Academia and Diagnostic Partners to accelerate R&D to commercialization by leveraging predictive biomarkers and clinical diagnostics evidence for best patient outcomes in target populations.
This meeting is free to attend for drug developers, researchers & academics!
Being held digitally on September 29 – 30, with 65+ expert speakers across 2 days of comprehensive content showcasing the freshest data paired with inspiring stories from innovative partnership collaborations to help you overcome your most pressing challenges and accelerate curative medicine for heterogeneous patient populations.
With 3-tracks addressing the entire lifecycle of biomarker-driven drug development, explore biomarkers and Dx movement within bioanalytical analysis, AI/ML application, data sharing and the regulatory and payer landscape. Covering immune-oncology, neurodegenerative, metabolic, autoimmune and rare indications, gain a diverse picture of today’s expanding personalized medicine ecosystem.
WHY SHOULD YOU ATTEND
With over half of drugs approved by the FDA now supported by a biomarker and as new CDx collaborations are announced on an almost weekly basis, demand for diagnostic tools enabling earlier, more precise, therapeutic interventions is at an all-time high.
2020 saw a huge uplift in terms of progresses in both biomarkers and CDx within precision medicine. It’s become almost a pre-requisite to embark on the search of clinical relevant and predictive biomarker from preclinical stage, and for drug developers to select and prioritize which drugs will benefit most by having a CDx.
As the trend in pharma/biotech is shifting to focus on targeted treatment, even if it means for a smaller patient population, the ability to identify a robust biomarker and CDx for patient stratification has never been more important.
With years of experience in oncology, drug developers are also branching out to other precision medicine’s modalities, specifically within CNS and neurodegenerative diseases; and leveraging new technology platforms for read outs.
The 11th World Clinical Biomarkers & CDx Summit is dedicated to bringing you the tools, insights and techniques to design a clinically robust biomarker and commercially competitive CDx!
EXPERT SPEAKERS INCLUDE
Access the Full Event Guide here for the complete expert speaker faculty and content-packed agenda.
